首页 > 最新文献

International Journal of Organ Transplantation Medicine最新文献

英文 中文
The Genotype Frequency of CYP2C19 Enzyme after Liver Transplantation. 肝移植后CYP2C19酶基因型频率的变化。
IF 0.7 Q3 Medicine Pub Date : 2019-01-01 Epub Date: 2019-05-01
P Badiee, Z Hashemizadeh, S A Malek-Hosseini, B Geramizadeh

Background: Liver transplant recipients are treated with various drugs, the metabolism of which is dependent on the cytochrome P450 polymorphic genotype.

Objective: To identify the polymorphic variety of CYP2C19 genotype in liver allograft before and after transplantation.

Methods: The study was conducted on 88 liver recipients. The CYP2C19 genotypes in donors and recipients were the same in 32 and different in 56 recipients. Extracted genomic DNA from the leukocytes and liver graft tissues were analyzed by TaqMan SNP genotyping assay. The distributions of homozygote, heterozygote, poor and ultra-rapid metabolizers' genotypes were investigated in both groups.

Results: The distributions of CYP2C19 genotypes before transplantation in the blood and liver graft were within the normal range. After transplantation, in patients with different CYP2C19 genotype in donors and recipients, the genotypes of homozygote and ultra-rapid metabolizers were significantly decreased (p=0.024); the heterozygotes and poor metabolizer genotypes were significantly increased (p=0.017).

Conclusion: The variety in CYP2C19 genotyping must be considered in patients with different genotypes in donor and recipients to predict the dosage regimens, optimize the treatment and decrease toxicity.

背景:肝移植受者接受多种药物治疗,这些药物的代谢依赖于细胞色素P450多态性基因型。目的:探讨同种异体肝移植前后CYP2C19基因型的多态性变化。方法:对88例肝脏受者进行研究。供体和受体CYP2C19基因型32例相同,56例不同。采用TaqMan SNP基因分型法对白细胞和肝移植组织提取的基因组DNA进行分析。研究了两组小鼠纯合子、杂合子、代谢不良者和超快速代谢者基因型的分布。结果:移植前血液和肝脏中CYP2C19基因型分布均在正常范围内。移植后,供体和受体CYP2C19基因型不同的患者,纯合子基因型和超快速代谢物基因型均显著降低(p=0.024);杂合子和低代谢基因型显著增加(p=0.017)。结论:在不同基因型的供受体患者中,CYP2C19基因分型的变化是预测给药方案、优化治疗方案、降低毒性的重要依据。
{"title":"The Genotype Frequency of CYP2C19 Enzyme after Liver Transplantation.","authors":"P Badiee,&nbsp;Z Hashemizadeh,&nbsp;S A Malek-Hosseini,&nbsp;B Geramizadeh","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Liver transplant recipients are treated with various drugs, the metabolism of which is dependent on the cytochrome P450 polymorphic genotype.</p><p><strong>Objective: </strong>To identify the polymorphic variety of CYP2C19 genotype in liver allograft before and after transplantation.</p><p><strong>Methods: </strong>The study was conducted on 88 liver recipients. The CYP2C19 genotypes in donors and recipients were the same in 32 and different in 56 recipients. Extracted genomic DNA from the leukocytes and liver graft tissues were analyzed by TaqMan SNP genotyping assay. The distributions of homozygote, heterozygote, poor and ultra-rapid metabolizers' genotypes were investigated in both groups.</p><p><strong>Results: </strong>The distributions of CYP2C19 genotypes before transplantation in the blood and liver graft were within the normal range. After transplantation, in patients with different CYP2C19 genotype in donors and recipients, the genotypes of homozygote and ultra-rapid metabolizers were significantly decreased (p=0.024); the heterozygotes and poor metabolizer genotypes were significantly increased (p=0.017).</p><p><strong>Conclusion: </strong>The variety in CYP2C19 genotyping must be considered in patients with different genotypes in donor and recipients to predict the dosage regimens, optimize the treatment and decrease toxicity.</p>","PeriodicalId":14242,"journal":{"name":"International Journal of Organ Transplantation Medicine","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604758/pdf/ijotm-10-093.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37128778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Idarucizumab in High-risk Thoracic Surgery. Idarucizumab在高危胸外科手术中的应用
IF 0.7 Q3 Medicine Pub Date : 2018-01-01 Epub Date: 2018-05-01
R López-Vilella, J Sanz-Sánchez, I Sánchez-Lázaro, E Marques-Sule, J Rueda-Soriano, L Almenar-Bonet

Direct oral anticoagulants have suggested a favorable profile compared with vitamin K antagonists. However, the lack of treatment to reverse the effect of direct oral anticoagulants has limited its use in some patients who require rapid reversal of anticoagulation, as those included in the transplant waiting list. Idarucizumab is a recently approved drug to reverse the anticoagulant effect of dabigatran. However, the clinical experience when using this drug is scarce. Herein, we present a clinical case on anticoagulation reversal with idarucizumab to perform heart and lung transplantation in a patient with Eisenmenger syndrome.

与维生素K拮抗剂相比,直接口服抗凝剂的效果更好。然而,缺乏逆转直接口服抗凝剂效果的治疗方法,限制了它在一些需要快速逆转抗凝治疗的患者中的应用,如那些在移植等待名单中的患者。Idarucizumab是最近批准的一种逆转达比加群抗凝作用的药物。然而,临床使用该药的经验很少。在这里,我们提出了一个临床病例抗凝逆转用依达鲁珠单抗进行心肺移植患者艾森曼格综合征。
{"title":"Idarucizumab in High-risk Thoracic Surgery.","authors":"R López-Vilella,&nbsp;J Sanz-Sánchez,&nbsp;I Sánchez-Lázaro,&nbsp;E Marques-Sule,&nbsp;J Rueda-Soriano,&nbsp;L Almenar-Bonet","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Direct oral anticoagulants have suggested a favorable profile compared with vitamin K antagonists. However, the lack of treatment to reverse the effect of direct oral anticoagulants has limited its use in some patients who require rapid reversal of anticoagulation, as those included in the transplant waiting list. Idarucizumab is a recently approved drug to reverse the anticoagulant effect of dabigatran. However, the clinical experience when using this drug is scarce. Herein, we present a clinical case on anticoagulation reversal with idarucizumab to perform heart and lung transplantation in a patient with Eisenmenger syndrome.</p>","PeriodicalId":14242,"journal":{"name":"International Journal of Organ Transplantation Medicine","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390979/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37024371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interaction between Herpes Virus Infections and IL10 and Risk of Bone Marrow Suppression. 疱疹病毒感染与IL10的相互作用及骨髓抑制的风险。
IF 0.7 Q3 Medicine Pub Date : 2018-01-01 Epub Date: 2018-08-01
R Yaghobi, F Alizadeh, A Khodavandi

Background: Syndrome of transient bone marrow suppression may result from various extra-hematological diseases, such as immunological deregulations, and viral infectious diseases secondarily affecting the function of hematopoietic stem cells.

Objective: To evaluate the pathogenic role of herpes viruses and their contraction with IL10 cytokine gene polymorphism, which can impair hematopoiesis in patients with transient bone marrow suppression.

Methods: In a cross-sectional study 30 patients who admitted to Namazi Hospital, affiliated to Shiraz University of Medical Sciences, with transient bone marrow suppression were recruited. Diagnosis of the transient bone marrow suppression was made by expert hematologists. A control group consisting of 100 healthy unrelated individuals was also included. One EDTA-treated blood sample was collected from each studied patients and plasma was isolated. The molecular prevalence of cytomegalovirus and HHV8 evaluated was evaluated using real-time and nested PCR protocols, respectively. The SNPs of the IL10 (rs 1800896-1082G/A) cytokine gene was evaluated by PCR-RFLP method.

Results: Cytomegalovirus and HHV8 infections were found in 2 and 3 of studied patients with transient bone marrow suppression. Significant higher frequency of IL10 G allele and GG genotype were found in HHV8-infected patients comparing to uninfected ones. Higher frequencies of A allele and AG and AA genotypes of IL10 were found in cytomegalovirus-uninfected patients comparing to infected ones, respectively. The significant higher frequencies of IL10 AA and AG genotypes were found in controls compared to bone marrow suppressed patients.

Conclusion: IL10 genetic polymorphism might have determinative role in resistance to the cytomegalovirus, especially HHV8 infections, in patients with bone marrow suppression. Focus in new interaction between HHV8 infection and IL10 genetics in bone marrow suppressed patients should be completed by the analysis of the anti-herpes virus immunity in future studies.

背景:短暂性骨髓抑制综合征可能是由各种血液外疾病引起的,如免疫调节失调和继发性影响造血干细胞功能的病毒性传染病。目的:用IL10细胞因子基因多态性评价疱疹病毒的致病作用及其对短暂性骨髓抑制患者造血功能的影响。方法:在一项横断面研究中,招募了30名入住设拉子医科大学附属Namazi医院的短暂性骨髓抑制患者。血液科专家诊断为短暂性骨髓抑制。由100名健康的无关个体组成的对照组也包括在内。从每个研究患者中采集一份EDTA处理的血样,并分离血浆。分别使用实时和嵌套PCR方案评估巨细胞病毒和HHV8的分子流行率。采用PCR-RFLP方法对IL10(rs1800896-1082G/A)细胞因子基因的SNPs进行检测。结果:在短暂骨髓抑制的研究患者中,2例和3例发现巨细胞病毒和HHV8感染。与未感染者相比,HHV8感染者的IL10 G等位基因和GG基因型频率明显更高。与感染者相比,未感染巨细胞病毒的患者中IL10的A等位基因和AG和AA基因型的频率分别较高。与骨髓抑制的患者相比,在对照组中发现IL10 AA和AG基因型的频率显著更高。结论:IL10基因多态性可能在骨髓抑制患者对巨细胞病毒特别是HHV8感染的抵抗中起决定性作用。在未来的研究中,应通过对抗疱疹病毒免疫的分析来完成对骨髓抑制患者中HHV8感染和IL10基因之间新的相互作用的关注。
{"title":"Interaction between Herpes Virus Infections and IL10 and Risk of Bone Marrow Suppression.","authors":"R Yaghobi,&nbsp;F Alizadeh,&nbsp;A Khodavandi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Syndrome of transient bone marrow suppression may result from various extra-hematological diseases, such as immunological deregulations, and viral infectious diseases secondarily affecting the function of hematopoietic stem cells.</p><p><strong>Objective: </strong>To evaluate the pathogenic role of herpes viruses and their contraction with <i>IL10</i> cytokine gene polymorphism, which can impair hematopoiesis in patients with transient bone marrow suppression.</p><p><strong>Methods: </strong>In a cross-sectional study 30 patients who admitted to Namazi Hospital, affiliated to Shiraz University of Medical Sciences, with transient bone marrow suppression were recruited. Diagnosis of the transient bone marrow suppression was made by expert hematologists. A control group consisting of 100 healthy unrelated individuals was also included. One EDTA-treated blood sample was collected from each studied patients and plasma was isolated. The molecular prevalence of cytomegalovirus and HHV8 evaluated was evaluated using real-time and nested PCR protocols, respectively. The SNPs of the <i>IL10</i> (rs 1800896-1082G/A) cytokine gene was evaluated by PCR-RFLP method.</p><p><strong>Results: </strong>Cytomegalovirus and HHV8 infections were found in 2 and 3 of studied patients with transient bone marrow suppression. Significant higher frequency of <i>IL10</i> G allele and GG genotype were found in HHV8-infected patients comparing to uninfected ones. Higher frequencies of A allele and AG and AA genotypes of <i>IL10</i> were found in cytomegalovirus-uninfected patients comparing to infected ones, respectively. The significant higher frequencies of <i>IL10</i> AA and AG genotypes were found in controls compared to bone marrow suppressed patients.</p><p><strong>Conclusion: </strong><i>IL10</i> genetic polymorphism might have determinative role in resistance to the cytomegalovirus, especially HHV8 infections, in patients with bone marrow suppression. Focus in new interaction between HHV8 infection and <i>IL10</i> genetics in bone marrow suppressed patients should be completed by the analysis of the anti-herpes virus immunity in future studies.</p>","PeriodicalId":14242,"journal":{"name":"International Journal of Organ Transplantation Medicine","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252181/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41130805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Massive Subcutaneous Emphysema, Pneumoperitoneum, Pneumoretroperitoneum, and Pneumoscrotum following Endoscopic Retrograde Cholangiopancreatography in a Living Liver Donor. 活体肝供者经内窥镜逆行胰胆管造影后发现大量皮下肺气肿、气腹、腹膜后气肿及阴囊。
IF 0.7 Q3 Medicine Pub Date : 2018-01-01 Epub Date: 2018-08-01
S Akbulut, B Isik, Y Karipkiz, S Yilmaz

Despite having many advantages, living donor liver transplantation has not been adopted by western countries due to risk of nearly life-threatening complications after living donor hepatectomy (LDH). Herein, we aimed at presenting the management of a 19-year-old patient who suffered life-threatening complications after right lobe LDH. A multiple detector computed tomography (MDCT) revealed a bilioma at the cut surface of the remnant liver, for which a transhepatic drainage catheter was placed. Endoscopic retrograde cholangiopancreatography (ERCP) performed to decompress biliary tract, but the biliary tract could not be cannulized due to post-precut bleeding. On the next day, extensive crepitation was detected and MDCT showed subcutaneous emphysema, pneumoperitoneum, pneumoretroperitoneum, and pneumoscrotum (ERCP-related duodenal perforation?). However, the patient showed significant deterioration of physical examination findings, fever, and infectious parameters, and therefore was taken to the operating room. Kocher maneuver revealed no apparent duodenal perforation. Then, a 2-mm bile duct was found open at the caudate lobe, through which bile leaked. Then, common bile duct exploration and T-tube placement were performed, followed by suture closure of the bile orifice at the caudate lobe. Massive air previously identified completely disappeared one week after the operation.

尽管活体肝移植有许多优点,但由于活体肝切除术(LDH)后几乎危及生命的并发症的风险,活体肝移植尚未被西方国家采用。在此,我们的目的是介绍一位19岁的患者在右肺LDH后遭受危及生命的并发症的处理。多检测器计算机断层扫描(MDCT)显示在残肝切面有胆囊瘤,为此放置了经肝引流管。行内镜逆行胆管造影(ERCP)对胆道进行减压,但由于术前出血,胆道无法插管。次日,大范围咯气,MDCT示皮下肺气肿、气腹、腹膜后气肿、阴囊气肿(ercp相关十二指肠穿孔)。然而,患者的体格检查结果、发热和感染参数明显恶化,因此被送往手术室。Kocher手法未见明显十二指肠穿孔。然后,在尾状叶发现一个2mm的胆管打开,胆汁通过该胆管流出。然后探查胆总管,放置t管,缝合尾状叶胆管口。此前确认的大量空气在行动一周后完全消失。
{"title":"Massive Subcutaneous Emphysema, Pneumoperitoneum, Pneumoretroperitoneum, and Pneumoscrotum following Endoscopic Retrograde Cholangiopancreatography in a Living Liver Donor.","authors":"S Akbulut,&nbsp;B Isik,&nbsp;Y Karipkiz,&nbsp;S Yilmaz","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Despite having many advantages, living donor liver transplantation has not been adopted by western countries due to risk of nearly life-threatening complications after living donor hepatectomy (LDH). Herein, we aimed at presenting the management of a 19-year-old patient who suffered life-threatening complications after right lobe LDH. A multiple detector computed tomography (MDCT) revealed a bilioma at the cut surface of the remnant liver, for which a transhepatic drainage catheter was placed. Endoscopic retrograde cholangiopancreatography (ERCP) performed to decompress biliary tract, but the biliary tract could not be cannulized due to post-precut bleeding. On the next day, extensive crepitation was detected and MDCT showed subcutaneous emphysema, pneumoperitoneum, pneumoretroperitoneum, and pneumoscrotum (ERCP-related duodenal perforation?). However, the patient showed significant deterioration of physical examination findings, fever, and infectious parameters, and therefore was taken to the operating room. Kocher maneuver revealed no apparent duodenal perforation. Then, a 2-mm bile duct was found open at the caudate lobe, through which bile leaked. Then, common bile duct exploration and T-tube placement were performed, followed by suture closure of the bile orifice at the caudate lobe. Massive air previously identified completely disappeared one week after the operation.</p>","PeriodicalId":14242,"journal":{"name":"International Journal of Organ Transplantation Medicine","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252177/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36716497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concurrent Umbilical Hernia Repair at the Time of Liver Transplantation: A Six-Year Experience from a Single Institution. 肝移植时脐疝同步修复:来自单一机构的六年经验。
IF 0.7 Q3 Medicine Pub Date : 2018-01-01 Epub Date: 2018-02-01
A J Perez, I N Haskins, A S Prabhu, D M Krpata, C Tu, S Rosenblatt, K Hashimoto, T Diago, B Eghtesad, M L J Rosen

Background: Umbilical hernias are common in patients with end-stage liver disease undergoing liver transplantation. Management of those persisting at the time of liver transplantation is important to define.

Objective: To evaluate the long-term results of patients undergoing simultaneous primary umbilical hernia repair (UHR) at the time of liver transplantation at a single institution.

Methods: Retrospective chart review was performed on patients undergoing simultaneous UHR and liver transplantation from 2010 through 2016. 30-day morbidity and mortality outcomes and long-term hernia recurrence were investigated.

Results: 59 patients had primary UHR at the time of liver transplantation. All hernias were reducible with no overlying skin breakdown or leakage of ascites. 30-day morbidity and mortality included 5 (8%) superficial surgical site infections, 1 (2%) deep surgical site infection, and 7 (12%) organ space infections. Unrelated to the UHR, 10 (17%) patients had an unplanned return to the operating room, 16 (27%) were readmitted within 30 days of their index operation, and 1 (2%) patient died. With a mean follow-up of 21.8 months, 7 (18%) patients experienced an umbilical hernia recurrence.

Conclusion: Despite the high perioperative morbidity associated with the transplant procedure, concurrent primary UHR resulted in an acceptable long-term recurrence rate with minimal associated morbidity.

背景:脐疝在接受肝移植的终末期肝病患者中很常见。肝移植时对那些持续存在的患者的处理是很重要的。目的:评价在同一医院同时行原发性脐疝修复术(UHR)的患者肝移植的长期疗效。方法:对2010年至2016年同时行UHR和肝移植的患者进行回顾性分析。观察30天的发病率、死亡率、预后及长期疝复发率。结果:59例患者在肝移植时发生原发性UHR。所有疝均可复位,无复盖皮肤破裂或腹水渗漏。30天的发病率和死亡率包括5例(8%)浅表手术部位感染,1例(2%)深部手术部位感染,7例(12%)器官间隙感染。与UHR无关,10例(17%)患者意外返回手术室,16例(27%)患者在首次手术后30天内再次入院,1例(2%)患者死亡。平均随访21.8个月,7例(18%)患者出现脐疝复发。结论:尽管移植手术的围手术期发病率很高,但并发原发性UHR导致了可接受的长期复发率和最小的相关发病率。
{"title":"Concurrent Umbilical Hernia Repair at the Time of Liver Transplantation: A Six-Year Experience from a Single Institution.","authors":"A J Perez,&nbsp;I N Haskins,&nbsp;A S Prabhu,&nbsp;D M Krpata,&nbsp;C Tu,&nbsp;S Rosenblatt,&nbsp;K Hashimoto,&nbsp;T Diago,&nbsp;B Eghtesad,&nbsp;M L J Rosen","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Umbilical hernias are common in patients with end-stage liver disease undergoing liver transplantation. Management of those persisting at the time of liver transplantation is important to define.</p><p><strong>Objective: </strong>To evaluate the long-term results of patients undergoing simultaneous primary umbilical hernia repair (UHR) at the time of liver transplantation at a single institution.</p><p><strong>Methods: </strong>Retrospective chart review was performed on patients undergoing simultaneous UHR and liver transplantation from 2010 through 2016. 30-day morbidity and mortality outcomes and long-term hernia recurrence were investigated.</p><p><strong>Results: </strong>59 patients had primary UHR at the time of liver transplantation. All hernias were reducible with no overlying skin breakdown or leakage of ascites. 30-day morbidity and mortality included 5 (8%) superficial surgical site infections, 1 (2%) deep surgical site infection, and 7 (12%) organ space infections. Unrelated to the UHR, 10 (17%) patients had an unplanned return to the operating room, 16 (27%) were readmitted within 30 days of their index operation, and 1 (2%) patient died. With a mean follow-up of 21.8 months, 7 (18%) patients experienced an umbilical hernia recurrence.</p><p><strong>Conclusion: </strong>Despite the high perioperative morbidity associated with the transplant procedure, concurrent primary UHR resulted in an acceptable long-term recurrence rate with minimal associated morbidity.</p>","PeriodicalId":14242,"journal":{"name":"International Journal of Organ Transplantation Medicine","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839626/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35906672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tools for the Measurement of Psychological Aspects of Organ Donation among the Families of Brain-dead People. 脑死亡患者家属器官捐献心理测量工具。
IF 0.7 Q3 Medicine Pub Date : 2018-01-01 Epub Date: 2018-05-01
S Ahmadian, M Khaghanizadeh, M H Zarghami, E Khaleghi, A Ebadi

Background: According to the basic ethical principle of non-maleficence, organ procurement systems need to be accountable to donor families. As organ donation can be potentially traumatic, donor families are at risk of developing psychological damage. Appropriate measurement tools are needed to diagnose such disorders and develop appropriate treatment measures.

Objective: To examine the appropriateness of measurement tools and approaches used in previous studies for assessing donor families' psychological well-being.

Methods: A structured online search was conducted in electronic databases namely ScienceDirect, PubMed, ProQuest, Scopus, Ovid, and Web of Science. The main inclusion criterion was the use of psychological assessment tools for data collection.

Results: 10 studies were included in which different tools had been used for measuring donor families' psychological well-being in the following 5 dimensions: stress, depression, grief, general health, and positive legacy of trauma. The major pitfalls of the reviewed studies were failure to specifically assess complicated grief and differentiating it from other psychological disorders, diversity of the tools used for psychological well-being assessment, and lack of clear definitions of donor families' psychological well-being and its dimensions.

Conclusion: Donor families' psychological well-being is a complex and multidimensional concept and the existing measurement tools cannot accurately assess it. Therefore, the concept needs to be clearly explored and defined. Developing a comprehensive measurement tool or a set of scales is necessary for the early diagnosis of any impairment in donor families' psychological well-being.

背景:根据非恶意的基本伦理原则,器官获取制度需要对供体家庭负责。由于器官捐赠可能带来潜在的创伤,捐赠家庭面临着心理伤害的风险。需要适当的测量工具来诊断这些疾病并制定适当的治疗措施。目的:检验以往研究中用于评估供体家庭心理健康的测量工具和方法的适宜性。方法:在ScienceDirect、PubMed、ProQuest、Scopus、Ovid、Web of Science等电子数据库中进行结构化在线检索。主要纳入标准是使用心理评估工具收集数据。结果:纳入了10项研究,其中使用了不同的工具来测量供体家庭在以下5个方面的心理健康:压力、抑郁、悲伤、一般健康和创伤的积极遗产。所审查的研究的主要缺陷是未能具体评估复杂悲伤并将其与其他心理障碍区分开来,用于心理健康评估的工具多样性,以及缺乏对捐赠者家庭心理健康及其维度的明确定义。结论:献血者家庭的心理健康是一个复杂的多维概念,现有的测量工具无法准确评估。因此,这个概念需要被清楚地探索和定义。开发一套全面的测量工具或一套量表对于早期诊断捐赠者家庭心理健康的任何损害是必要的。
{"title":"Tools for the Measurement of Psychological Aspects of Organ Donation among the Families of Brain-dead People.","authors":"S Ahmadian,&nbsp;M Khaghanizadeh,&nbsp;M H Zarghami,&nbsp;E Khaleghi,&nbsp;A Ebadi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>According to the basic ethical principle of non-maleficence, organ procurement systems need to be accountable to donor families. As organ donation can be potentially traumatic, donor families are at risk of developing psychological damage. Appropriate measurement tools are needed to diagnose such disorders and develop appropriate treatment measures.</p><p><strong>Objective: </strong>To examine the appropriateness of measurement tools and approaches used in previous studies for assessing donor families' psychological well-being.</p><p><strong>Methods: </strong>A structured online search was conducted in electronic databases namely <i>ScienceDirect, PubMed, ProQuest, Scopus, Ovid,</i> and <i>Web of Science</i>. The main inclusion criterion was the use of psychological assessment tools for data collection.</p><p><strong>Results: </strong>10 studies were included in which different tools had been used for measuring donor families' psychological well-being in the following 5 dimensions: stress, depression, grief, general health, and positive legacy of trauma. The major pitfalls of the reviewed studies were failure to specifically assess complicated grief and differentiating it from other psychological disorders, diversity of the tools used for psychological well-being assessment, and lack of clear definitions of donor families' psychological well-being and its dimensions.</p><p><strong>Conclusion: </strong>Donor families' psychological well-being is a complex and multidimensional concept and the existing measurement tools cannot accurately assess it. Therefore, the concept needs to be clearly explored and defined. Developing a comprehensive measurement tool or a set of scales is necessary for the early diagnosis of any impairment in donor families' psychological well-being.</p>","PeriodicalId":14242,"journal":{"name":"International Journal of Organ Transplantation Medicine","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390983/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37023414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tacrolimus-induced Ascites after Liver Transplant. 他克莫司致肝移植术后腹水。
IF 0.7 Q3 Medicine Pub Date : 2018-01-01 Epub Date: 2018-05-01
M Hosseini, M Aliakbarian, K Akhavan-Rezayat, O Shadkam, S Milani

Massive post-transplantation ascites is a rare but serious condition following liver transplantation. Although, many etiologies are suggested as the cause of this complication, in some cases the definitive etiology remains unknown. Drug-induced post-transplantation ascites is one of the possible etiologies. In this study we present a case of ascites caused by tacrolimus in the post-liver transplantation period. A 49-year-old man with hepatitis B virus cirrhosis underwent liver transplantation and received tacrolimus, mycophenolate and prednisolone, as the immunosuppressive regimen. Progressive ascites developed after 10 days, in spite of a normal liver function. Various studies, including liver biopsy, were performed but we could not find any etiology for this complication. The tacrolimus was switched to rapamune. Ascites was completely disappeared and up to the last follow-up visit, the patient remained asymptomatic for more than two years. We concluded that after ruling out other etiologies, tacrolimus as a rare cause of post-transplantation ascites should be taken into account. The treatment is discontinuation of the drug.

肝移植术后大量腹水是一种罕见但严重的情况。虽然,许多病因被认为是导致这种并发症的原因,但在某些情况下,明确的病因仍然未知。药物性移植后腹水是可能的病因之一。在这项研究中,我们提出了一例他克莫司在肝移植后引起的腹水。1例49岁乙型肝炎肝硬化患者行肝移植,并接受他克莫司、麦考酚酸盐和强的松龙作为免疫抑制方案。尽管肝功能正常,但10天后出现了进行性腹水。进行了各种研究,包括肝活检,但我们无法找到任何并发症的病因。他克莫司换成了雷帕莫。腹水完全消失,直到最后一次随访,患者无症状持续两年多。我们的结论是,在排除其他病因后,他克莫司作为移植后腹水的罕见病因应予以考虑。治疗方法是停药。
{"title":"Tacrolimus-induced Ascites after Liver Transplant.","authors":"M Hosseini,&nbsp;M Aliakbarian,&nbsp;K Akhavan-Rezayat,&nbsp;O Shadkam,&nbsp;S Milani","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Massive post-transplantation ascites is a rare but serious condition following liver transplantation. Although, many etiologies are suggested as the cause of this complication, in some cases the definitive etiology remains unknown. Drug-induced post-transplantation ascites is one of the possible etiologies. In this study we present a case of ascites caused by tacrolimus in the post-liver transplantation period. A 49-year-old man with hepatitis B virus cirrhosis underwent liver transplantation and received tacrolimus, mycophenolate and prednisolone, as the immunosuppressive regimen. Progressive ascites developed after 10 days, in spite of a normal liver function. Various studies, including liver biopsy, were performed but we could not find any etiology for this complication. The tacrolimus was switched to rapamune. Ascites was completely disappeared and up to the last follow-up visit, the patient remained asymptomatic for more than two years. We concluded that after ruling out other etiologies, tacrolimus as a rare cause of post-transplantation ascites should be taken into account. The treatment is discontinuation of the drug.</p>","PeriodicalId":14242,"journal":{"name":"International Journal of Organ Transplantation Medicine","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390981/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37024373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fatal Case of Pulmonary Invasive Aspergillus after Heart Transplant with a Rapidly Progressive Course. 心脏移植后肺部侵袭性曲霉菌死亡病例,病程进展迅速。
IF 0.7 Q3 Medicine Pub Date : 2018-01-01 Epub Date: 2018-08-01
B Shakerian, N Razavi, M H Mandegar

The incidence of invasive fungal infections is lower than that of bacterial infections in heart transplant recipients. However, they are always life-threatening. Clinical manifestations may range from asymptomatic colonization to disseminated infection. This complication is responsible for significant morbidity and mortality, particularly in heart transplant recipients. Herein, we present on a cardiac transplant recipient who presented with invasive pulmonary aspergillosis quickly leading to death, in spite of early diagnosis and aggressive therapy. It just took 10 hours from the diagnosis to death. In other reports, this period was at least 12 days.

在心脏移植受者中,侵袭性真菌感染的发病率低于细菌感染。但是,真菌感染总是会危及生命。临床表现可从无症状定植到播散性感染。这种并发症会导致严重的发病率和死亡率,尤其是在心脏移植受者中。在此,我们介绍了一名心脏移植受者的病例,尽管他得到了早期诊断和积极治疗,但还是很快患上了侵袭性肺部曲霉菌病,最终导致死亡。从确诊到死亡仅用了 10 个小时。而在其他报告中,这段时间至少需要 12 天。
{"title":"Fatal Case of Pulmonary Invasive Aspergillus after Heart Transplant with a Rapidly Progressive Course.","authors":"B Shakerian, N Razavi, M H Mandegar","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The incidence of invasive fungal infections is lower than that of bacterial infections in heart transplant recipients. However, they are always life-threatening. Clinical manifestations may range from asymptomatic colonization to disseminated infection. This complication is responsible for significant morbidity and mortality, particularly in heart transplant recipients. Herein, we present on a cardiac transplant recipient who presented with invasive pulmonary aspergillosis quickly leading to death, in spite of early diagnosis and aggressive therapy. It just took 10 hours from the diagnosis to death. In other reports, this period was at least 12 days.</p>","PeriodicalId":14242,"journal":{"name":"International Journal of Organ Transplantation Medicine","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252175/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36716499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Leflunomide for BKvirus: Report of Seven Kidney-Transplanted Children. 来氟米特治疗bk病毒:7例肾移植儿童报告。
IF 0.7 Q3 Medicine Pub Date : 2018-01-01 Epub Date: 2018-11-01
M Launay, V Baudouin, R Guillemain, A Maisin, H Flodrops, E Douez, S Mavoungou, V Jullien, E M Billaud

Background: Leflunomide is an immunosuppressive agent commercialized for treatment of rheumatoid arthritis. Because of its immunosuppressive and possible antiviral properties, leflunomide has been evaluated in some case series of BKVAN with favorable results, mostly in adult patients. Leflunomide targeted levels are usually between 50 and 100 mg/L in kidney transplant adult patients. Data in pediatric population are scarce.

Objective: To assess the effect of leflunomide on BKvirus in kidney-transplanted children.

Methods: Therapeutic drug monitoring of leflunomide is routinely performed by measuring its active metabolite, teriflunomide, using a simple HPLC-UV method. Pediatric kidney transplant patients with at least one teriflunomide sample between 2010 and 2017 were retrospectively included in this study. Viremia control was defined as undetectable BK viremia or a decrease of more than 1 log in the viral load from the baseline after two months of treatment. Adverse events were recorded.

Results: A total of 7 patients from 3 centers was included. 6 were only kidney transplant recipients; 1 was a lung-kidney transplant recipient with cystic fibrosis. All patients reported high load BK viremia but none developed BKVAN. For 67% of the patients, complete BK viral clearance was observed during leflunomide treatment with drastic immunosuppressive therapy reduction. Mycophenolate was indeed discontinued in almost all patients. Of note, leflunomide concentrations were significantly higher when viremia was controlled. Only 33% of the observed concentrations were >40 mg/L. The patient with cystic fibrosis had lower concentrations with higher drug doses. No hepatotoxicity was observed in this study and no patient experienced graft rejection. Leflunomide was suspected to cause hemolytic anemia and one patient experienced biological pancreatitis.

Conclusion: This study evidenced the wide interindividual variability of the exposure and supported the routine practice of leflunomide with a suggested target level of 30-40 mg/L in pediatric kidney transplanted patient. However, because of the very limited number of patients in our series, further investigations are needed to validate this suggestion.

背景:来氟米特是一种商业化用于治疗类风湿性关节炎的免疫抑制剂。由于其免疫抑制和可能的抗病毒特性,来氟米特在一些BKVAN病例系列中得到了良好的结果,主要是在成人患者中。成年肾移植患者来氟米特的靶水平通常在50 - 100mg /L之间。儿科人群的数据很少。目的:评价来氟米特对肾移植患儿BKvirus的影响。方法:采用简单的高效液相色谱-紫外分光光度法测定来氟米特的活性代谢物特立氟米特,对来氟米特的治疗药物进行常规监测。2010年至2017年间至少使用一种特立氟米特样本的儿童肾移植患者被回顾性纳入本研究。病毒血症控制被定义为无法检测到的BK病毒血症,或治疗两个月后病毒载量较基线下降1个百分点以上。记录不良事件。结果:共纳入3个中心的7例患者。6例仅接受肾移植;1例肺肾移植患者伴有囊性纤维化。所有患者均报告高负荷BK病毒血症,但未发生BKVAN。67%的患者在来氟米特治疗期间观察到完全的BK病毒清除,免疫抑制治疗急剧减少。几乎所有患者都停用了霉酚酸盐。值得注意的是,当病毒血症得到控制时,来氟米特浓度显著升高。只有33%的观察浓度>40 mg/L。囊性纤维化患者药物剂量越大,浓度越低。在这项研究中没有观察到肝毒性,也没有患者出现移植排斥反应。来氟米特被怀疑引起溶血性贫血,一名患者出现了生物性胰腺炎。结论:本研究证明了来氟米特暴露的广泛个体差异,并支持了来氟米特在儿童肾移植患者中的常规应用,建议目标水平为30- 40mg /L。然而,由于我们研究的患者数量非常有限,需要进一步的研究来验证这一建议。
{"title":"Leflunomide for BKvirus: Report of Seven Kidney-Transplanted Children.","authors":"M Launay,&nbsp;V Baudouin,&nbsp;R Guillemain,&nbsp;A Maisin,&nbsp;H Flodrops,&nbsp;E Douez,&nbsp;S Mavoungou,&nbsp;V Jullien,&nbsp;E M Billaud","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Leflunomide is an immunosuppressive agent commercialized for treatment of rheumatoid arthritis. Because of its immunosuppressive and possible antiviral properties, leflunomide has been evaluated in some case series of BKVAN with favorable results, mostly in adult patients. Leflunomide targeted levels are usually between 50 and 100 mg/L in kidney transplant adult patients. Data in pediatric population are scarce.</p><p><strong>Objective: </strong>To assess the effect of leflunomide on BKvirus in kidney-transplanted children.</p><p><strong>Methods: </strong>Therapeutic drug monitoring of leflunomide is routinely performed by measuring its active metabolite, teriflunomide, using a simple HPLC-UV method. Pediatric kidney transplant patients with at least one teriflunomide sample between 2010 and 2017 were retrospectively included in this study. Viremia control was defined as undetectable BK viremia or a decrease of more than 1 log in the viral load from the baseline after two months of treatment. Adverse events were recorded.</p><p><strong>Results: </strong>A total of 7 patients from 3 centers was included. 6 were only kidney transplant recipients; 1 was a lung-kidney transplant recipient with cystic fibrosis. All patients reported high load BK viremia but none developed BKVAN. For 67% of the patients, complete BK viral clearance was observed during leflunomide treatment with drastic immunosuppressive therapy reduction. Mycophenolate was indeed discontinued in almost all patients. Of note, leflunomide concentrations were significantly higher when viremia was controlled. Only 33% of the observed concentrations were >40 mg/L. The patient with cystic fibrosis had lower concentrations with higher drug doses. No hepatotoxicity was observed in this study and no patient experienced graft rejection. Leflunomide was suspected to cause hemolytic anemia and one patient experienced biological pancreatitis.</p><p><strong>Conclusion: </strong>This study evidenced the wide interindividual variability of the exposure and supported the routine practice of leflunomide with a suggested target level of 30-40 mg/L in pediatric kidney transplanted patient. However, because of the very limited number of patients in our series, further investigations are needed to validate this suggestion.</p>","PeriodicalId":14242,"journal":{"name":"International Journal of Organ Transplantation Medicine","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409091/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37224695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-transplantation Presentation of ANCA-associated Vasculitis: Granulomatosis with Polyangitis. 移植后anca相关血管炎的表现:肉芽肿病伴多血管炎。
IF 0.7 Q3 Medicine Pub Date : 2018-01-01 Epub Date: 2018-11-01
M A Shafiee, G Parastandechehr, S Taba Taba Vakili, M Shahroukh, A Haghighi, B Broumand

Granulomatosis with polyangitis (GPA) is characterized by necrotizing granulomatosis of the upper and lower respiratory tract and glomerulonephritis. If GPA does not respond to appropriate management, it might result in end-stage renal disease, which may remit the disease severity. The overall impression is that immunosuppression following renal transplantation would further subside the vasculitis. However, several studies have shown that systemic vasculitis recur in 25% of patients following renal transplantation. This may indicate the perplexing nature of the immune system. One of the key factors in prevention of relapse of GPA is following up of patients by careful immunosuppressive dose adjustment and regular measurement of biomarkers for vasculitis. Herein, we describe an interesting case of biopsy-proven GPA who had a complex long history of several post-transplantation relapses in different organs with anti-neutrophil cytoplasmic antibodies seroconversion. This case emphasizes that vasculitis in particular GPA can mimic various diseases depending on which vessels and organs are affected by the inflammation and is one of the reversible causes of failure of transplanted kidney. Bearing the diagnosis in mind as one of the potential differential diagnoses of failure of renal transplantation will lead to early diagnosis and treatment of recurrent GPA.

多血管炎肉芽肿病(GPA)的特点是上呼吸道和下呼吸道坏死性肉芽肿病和肾小球肾炎。如果GPA没有得到适当的治疗,可能会导致终末期肾脏疾病,这可能会减轻疾病的严重程度。总的印象是,肾移植后的免疫抑制将进一步缓解血管炎。然而,一些研究表明,25%的肾移植术后患者会复发全身性血管炎。这可能表明了免疫系统令人困惑的本质。预防GPA复发的关键因素之一是通过仔细调整免疫抑制剂量和定期测量血管炎的生物标志物对患者进行随访。在此,我们描述了一个有趣的活组织检查证实的GPA病例,他有几个移植后不同器官复发的复杂的长期历史,并伴有抗中性粒细胞细胞质抗体血清转化。这个病例强调血管炎,特别是GPA,可以模仿各种疾病,这取决于受炎症影响的血管和器官,是移植肾衰竭的可逆原因之一。将诊断作为肾移植失败的潜在鉴别诊断之一,将有助于早期诊断和治疗复发性GPA。
{"title":"Post-transplantation Presentation of ANCA-associated Vasculitis: Granulomatosis with Polyangitis.","authors":"M A Shafiee,&nbsp;G Parastandechehr,&nbsp;S Taba Taba Vakili,&nbsp;M Shahroukh,&nbsp;A Haghighi,&nbsp;B Broumand","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Granulomatosis with polyangitis (GPA) is characterized by necrotizing granulomatosis of the upper and lower respiratory tract and glomerulonephritis. If GPA does not respond to appropriate management, it might result in end-stage renal disease, which may remit the disease severity. The overall impression is that immunosuppression following renal transplantation would further subside the vasculitis. However, several studies have shown that systemic vasculitis recur in 25% of patients following renal transplantation. This may indicate the perplexing nature of the immune system. One of the key factors in prevention of relapse of GPA is following up of patients by careful immunosuppressive dose adjustment and regular measurement of biomarkers for vasculitis. Herein, we describe an interesting case of biopsy-proven GPA who had a complex long history of several post-transplantation relapses in different organs with anti-neutrophil cytoplasmic antibodies seroconversion. This case emphasizes that vasculitis in particular GPA can mimic various diseases depending on which vessels and organs are affected by the inflammation and is one of the reversible causes of failure of transplanted kidney. Bearing the diagnosis in mind as one of the potential differential diagnoses of failure of renal transplantation will lead to early diagnosis and treatment of recurrent GPA.</p>","PeriodicalId":14242,"journal":{"name":"International Journal of Organ Transplantation Medicine","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409092/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37224696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Organ Transplantation Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1